SCHEMBL7096617

SCHEMBL7096617

O=C1CCN(Cc2cc(C(F)(F)F)nc3c(C(F)(F)F)cccc23)C(=O)C(Cc2c[nH]c3ccccc23)N1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 4/20 0.53
▸ KMT2A Q03164 5/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ MAPT P10636 2/20 0.43
▸ HDAC1 Q13547 2/20 0.43
▸ HDAC8 Q9BY41 2/20 0.43
▸ HDAC6 Q9UBN7 2/20 0.43
▸ HDAC4 P56524 1/20 0.43
▸ HDAC7 Q8WUI4 1/20 0.43
▸ HDAC10 Q969S8 1/20 0.43
▸ HDAC11 Q96DB2 1/20 0.43
▸ HDAC9 Q9UKV0 1/20 0.43
▸ HDAC5 Q9UQL6 1/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ IDO1 P14902 1/20 0.42
▸ RIPK1 Q13546 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5229359 1.00 TACR1 (0.53) TACR1KMT2AMEN1MAPTHDAC1
SCHEMBL5234092 0.79 KMT2A (0.67) TACR1KMT2AMEN1MAPTHDAC1
SCHEMBL5230347 0.79 TACR1 (0.83) TACR1KMT2AMEN1HDAC1HDAC8
SCHEMBL5236172 0.79 TACR1 (0.61) TACR1KMT2AMEN1HDAC1HDAC8
SCHEMBL5231559 0.74 TACR1 (0.49) TACR1KMT2AMEN1MAPTHDAC1
SCHEMBL5229392 0.72 KMT2A (0.49) TACR1KMT2AMEN1MAPTHDAC1
SCHEMBL4287307 0.67 HDAC1 (0.75) TACR1KMT2AMEN1MAPTHDAC1
SCHEMBL7822959 0.67 HDAC1 (0.75) TACR1KMT2AMEN1MAPTHDAC1
SCHEMBL7838849 0.66 TACR1 (0.51) TACR1KMT2AMEN1MAPTL3MBTL1
SCHEMBL7824526 0.66 TACR1 (0.51) TACR1KMT2AMEN1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296961-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2003-04-02 — — EP disclosed
WO-2001090083-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-11-29 — — WO disclosed
Send feedback